Boston Scientificvs.Zimmer Biomet
BSX vs ZBH · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices — from surgery and cardiology to robotics.
Boston Scientific is about 3.8× larger than Zimmer Biomet by market cap; Boston Scientific trades at the lower P/E (18.7 vs 23.2); year to date, Zimmer Biomet leads (+1.6% vs −53.0%).
Side by side
| BSX | ZBH | |
|---|---|---|
| Market cap | $66.5B | $17.6B |
| Price | $44.77 | $91.34 |
| Today | −0.5% | +2.4% |
| Return YTD | −53.0% | +1.6% |
| Return 1Y | −56.9% | −4.0% |
| P/E | 18.7 | 23.2 |
| P/S | 3.2 | 2.1 |
| P/B | 2.6 | 1.4 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Boston ScientificBSX
American medtech company with strong growth in cardiology — including electrophysiology (Farapulse) and structural heart treatment.
Full BSX profile →More comparisons in Medtech & devices
See where BSX and ZBH sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →